In the HER2 transgenic spontaneous mammary tumor mouse model, we found a similar conclusion that ADAMTS18 deletion leads to the enhancement of integrin-mediated PI3K/AKT, ERK, and JNK signal activity, which increases the risk of mammary hyperplasia and breast cancer occurrence and metastasis (57). The gene discussed is AKT1; the disease is breast carcinoma.